Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Nov 29;327(7426):1264.
doi: 10.1136/bmj.327.7426.1264.

Coronary heart disease prevention: insights from modelling incremental cost effectiveness

Tom Marshall  1
Affiliations

Coronary heart disease prevention: insights from modelling incremental cost effectiveness

Tom Marshall. BMJ. .

Erratum in

  • BMJ. 2004 Jan 24;328(7433):209

Abstract

Objective: To determine which treatments for preventing coronary heart disease should be offered to which patients by assessing their incremental cost effectiveness.

Design: Modelling study.

Data sources: Cost estimates (for NHS) and estimates of effectiveness obtained for aspirin, antihypertensive drugs, statins and clopidogrel.

Data synthesis: Treatment effects were assumed to be independent, and cost per coronary event prevented was calculated for treatments individually and in combination across patients at a range of coronary risks.

Results: The most cost effective preventive treatments are aspirin, initial antihypertensive treatment (bendrofluazide and atenolol), and intensive antihypertensive treatment (bendrofluazide, atenolol and enalapril), whereas simvastatin and clopidogrel are the least cost effective (cost per coronary event prevented in a patient at 10% coronary risk over five years is 3500 pounds sterling for aspirin, 12 500 pounds sterling for initial antihypertensives, 18 300 pounds sterling for intensive antihypertensives, 60 000 pounds sterling for clopidogrel, and 61 400 pounds sterling for simvastatin). Aspirin in a patient at 5% five year coronary risk costs less than a fifth as much per event prevented (7900 pounds sterling) as simvastatin in a patient at 30% five year risk (40 800 pounds sterling).

Discussion: A cost effective prevention strategy would offer aspirin and initial antihypertensive treatment to all patients at greater than 7.5% five year coronary risk before offering statins or clopidogrel to patients at greater than 15% five year coronary risk. Incremental cost effectiveness analysis of treatments produces robust, practical cost effectiveness rankings that can be used to inform treatment guidelines.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Average cost effectiveness of preventive treatments in a patient at 10.5% risk of a coronary event over five years. (Error bars represent cost per coronary event prevented if effectiveness is at upper and lower 95% confidence limit)
See this image and copyright information in PMC

Comment in

References

    1. Department of Health. Chapter 2: Preventing coronary heart disease in high risk patients. In: National service framework for coronary heart disease. London: DoH, 2000: 1-32.
    1. Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny. BMJ 2002;324: 1570-6. - PMC - PubMed
    1. Marshall T, Rouse A. Resource implications and health benefits of primary prevention strategies for coronary disease in people aged 30 to 74: mathematical modelling study. BMJ 2002;325: 197-9. - PMC - PubMed
    1. National Institute for Clinical Excellence. NICE technical guidance for manufacturers and sponsors on making a submission to a technology appraisal. London: NICE, 2001.
    1. Netten A, Curtil L. Unit costs of health and social care 2001. Canterbury: Personal Social Services Research Unit, University of Kent, 2001.

MeSH terms